| Maysoon M Saeed, DDS | |
|
710 S Brookhurst St Ste K, Anaheim, CA 92804-4321 | |
| (714) 758-0778 | |
| (714) 758-0758 |
| Full Name | Maysoon M Saeed |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 710 S Brookhurst St Ste K, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174653687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 50819 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maysoon M Saeed, DDS 710 S Brookhurst St Ste K, Anaheim, CA 92804-4321 Ph: (714) 758-0778 | Maysoon M Saeed, DDS 710 S Brookhurst St Ste K, Anaheim, CA 92804-4321 Ph: (714) 758-0778 |
News Archive
In a paper recently uploaded to the preprint server bioRxiv by Kirchhoff et al. (May 31st, 2021) it is demonstrated that a single mutation to the RaTG13 spike protein results in significantly greater affinity towards the human receptor, indicating that the presence of a positively charged amino group at this position better facilitates interaction with the human ACE2 receptor, and helping to identify other viruses with zoonotic potential.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) amendment to conduct a Phase II clinical trial in the U.S. of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).
Vanda Pharmaceuticals Inc. presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals.
When a child has autism, siblings are also at risk for the disorder. New research from Washington University School of Medicine in St. Louis shows that the genetic reach of the disorder often extends to half siblings as well.
› Verified 9 days ago
Ms. Cynthia Bich Van Nguyen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 927 N Euclid Street, Anaheim, CA 92801 Phone: 714-991-7140 Fax: 714-991-7141 | |
Jack Ringer, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5765 E Santa Ana Canyon Rd Ste A, Anaheim, CA 92807 Phone: 714-974-0313 Fax: 714-974-3332 | |
Dr. Michael P Blum, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1211 W La Palma Ave, Suite 604, Anaheim, CA 92801 Phone: 714-772-2200 Fax: 714-520-0969 | |
Dr. Vicky Duong, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1602 N Lemon St, Anaheim, CA 92801 Phone: 714-525-5558 Fax: 714-525-8238 | |
Dr. Mike M Kang, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 2170 W Lincoln Ave, Anaheim, CA 92801 Phone: 424-343-9009 | |
Dr. Chia-lun Tsao, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 10600 Katella Ave, Anaheim, CA 92804 Phone: 714-758-7777 | |
Dr. Rosetta J Vergel De Dios, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1691 S Euclid St, Anaheim, CA 92802 Phone: 714-991-7572 Fax: 714-991-7756 |